Presentation Information
[P-35]ヒトパピローマウイルス（HPV）ワクチン積極的勧奨の再開後における接種状況の分析（2022〜2024年度）
*Kaori Tanaka1, Norihisa Yamamoto1, Toshie Yoshida1, Mai Okuyama1, Saeko Morino1, Takashi Ono1, Ayu Kasamatsu2, Masaki Ochiai3, Motoi Suzuki2, Sayaka Takanashi1 (1. Department of Immunization Research, National Institute of Infectious Diseases, Japan Institute for Health Security, Japan, 2. Center for Infectious Disease Epidemiology, National Institute of Infectious Diseases, Japan Institute for Health Security, Japan, 3. Center for Quality Management Systems, National Institute of Infectious Diseases, Japan Institute for Health Security, Japan)